[ FDA ENFORCEMENT INTELLIGENCE ]

Learn from the record. Every FDA recall is a quality signal.

Live drug, device & food recall data from the FDA (openFDA enforcement) — food spanning dietary supplements, cosmetics & animal food — mapped to the GxP quality domains SPEQ assesses, so you can see where control breaks down across every regulated industry.

1,000

Total recalls

217

Class I (most serious)

167

Drug

515

Device

318

Food / supplement / cosmetic

Last 12 months · latest report 2026-07-22 · source: openFDA enforcement

RECALLS BY CLASSIFICATION · MONTHLY

RECALL REASONS BY QUALITY DOMAIN

Domain mapping is a SPEQ interpretation of the FDA recall reason, not an official FDA classification.

409 matching recalls

Date	Class	Firm	Reason	Quality domain
2026-03-11	Class II	ACME UNITED CORPORATIOND-0368-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0376-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0366-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0362-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0375-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0373-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0369-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0358-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0367-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0364-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0361-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0360-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0365-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0371-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0374-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0370-2026	CGMP Deviations	Risk Management & CAPA
2026-03-11	Class II	ACME UNITED CORPORATIOND-0372-2026	CGMP Deviations	Risk Management & CAPA
2026-02-18	Class II	Pro Numb Tattoo Numbing Spray LLCD-0302-2026	cGMP deviations	Risk Management & CAPA
2026-02-18	Class II	Pro Numb Tattoo Numbing Spray LLCD-0303-2026	cGMP deviations	Risk Management & CAPA
2026-02-11	Class I	HANDELNINE GLOBAL LLCD-0332-2026	CGMP Deviations: product found to contain lead.	Risk Management & CAPA
2026-02-04	Class II	Weaver's Brew LLCH-0438-2026	Ginger Beer products might contain ginger juice that did not undergo the required pasteurization process.	Risk Management & CAPA
2026-02-04	Class II	Weaver's Brew LLCH-0435-2026	Ginger Beer products might contain ginger juice that did not undergo the required pasteurization process.	Risk Management & CAPA
2026-02-04	Class II	Weaver's Brew LLCH-0436-2026	Ginger Beer products might contain ginger juice that did not undergo the required pasteurization process.	Risk Management & CAPA
2026-02-04	Class II	Weaver's Brew LLCH-0437-2026	Ginger Beer products might contain ginger juice that did not undergo the required pasteurization process.	Risk Management & CAPA
2026-02-04	Class II	Weaver's Brew LLCH-0439-2026	Ginger Beer products might contain ginger juice that did not undergo the required pasteurization process.	Risk Management & CAPA

Page 12 of 17

← Prev Next →

Data: U.S. FDA openFDA enforcement API. Quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Recall details are as reported by the FDA.